Therapeutic potential of CDK inhibitors in MLL leukemias

被引：1
|
作者：
Frame, Sheelagh
Hogben, Morag
Munro, Clare
Blake, David G.
Green, Simon R.
Zheleva, Danielle I.
机构：
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/1538-7445.AM10-3886
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3886
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Potential role for wild-type p53 in leukemias with MLL gene translocations
    Maureen D Megonigal
    Eric F Rappaport
    Peter C Nowell
    Beverly J Lange
    Carolyn A Felix
    Oncogene, 1998, 16 : 1351 - 1356
  • [42] The therapeutic potential of phosphatase inhibitors
    Vintonyak, Viktor V.
    Antonchick, Andrey P.
    Rauh, Daniel
    Waldmann, Herbert
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2009, 13 (03) : 272 - 283
  • [43] Chymase inhibitors and their therapeutic potential
    Akahoshi, F
    DRUGS OF THE FUTURE, 2002, 27 (08) : 765 - 770
  • [44] Therapeutic Potential of Lipoprotein(a) Inhibitors
    Nicholls, Stephen J.
    DRUGS, 2024, 84 (06) : 637 - 643
  • [45] The therapeutic potential of aromatase inhibitors
    Miller, WR
    Jackson, J
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (03) : 337 - 351
  • [46] Maintaining Drosha expression with Cdk5 inhibitors as a potential therapeutic strategy for early intervention after TBI
    Huang, Lu
    Xia, Li
    Nie, Tiejian
    Cui, Bozhou
    Lu, Jianjun
    Lu, Fangfang
    Fan, Feiyan
    Ren, Dongni
    Lu, Yuan
    Gao, Guodong
    Yang, Qian
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2024, 56 (01): : 210 - 219
  • [47] Heterocyclic Compounds as CDK9 Inhibitors: Structural Diversity, Mechanism of Action, and Therapeutic Potential in Cancer and Beyond
    Bose, Kuntal
    Shajahan, Afiya
    Sreekumar, Nandana
    Aneesh, T. P.
    CHEMISTRY & BIODIVERSITY, 2025, 22 (01)
  • [48] Maintaining Drosha expression with Cdk5 inhibitors as a potential therapeutic strategy for early intervention after TBI
    Lu Huang
    Li Xia
    Tiejian Nie
    Bozhou Cui
    Jianjun Lu
    Fangfang Lu
    Feiyan Fan
    Dongni Ren
    Yuan Lu
    Guodong Gao
    Qian Yang
    Experimental & Molecular Medicine, 2024, 56 : 210 - 219
  • [49] CDK12: a potential therapeutic target in cancer
    Emadi, Fatemeh
    Teo, Theodosia
    Rahaman, Muhammed H.
    Wang, Shudong
    DRUG DISCOVERY TODAY, 2020, 25 (12) : 2257 - 2267
  • [50] CDK9 as a potential therapeutic target in sarcomas
    Matsumura, Yuta
    Umehara, Hiroki
    Oishi, Jun
    Siddiqui, Adam
    Foulks, Jason M.
    Yamamoto, Setsuko
    Warner, Steven L.
    CANCER RESEARCH, 2022, 82 (12)
12345